Yersinia pestis Activates Both IL-1β and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague

被引:26
|
作者
Sivaraman, Vijay [1 ,2 ]
Pechous, Roger D. [1 ]
Stasulli, Nikolas M. [1 ]
Miao, Edward A. [1 ]
Goldman, William E. [1 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA
[2] N Carolina Cent Univ, Dept Biol, Durham, NC USA
基金
美国国家卫生研究院;
关键词
CASPASE-1; ACTIVATION; IMMUNE-RESPONSES; SECRETION; INNATE; VIRULENCE; RECOGNITION; MACROPHAGES; PATHOLOGY; PROTEIN; INJURY;
D O I
10.1371/journal.ppat.1004688
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumonic plague is the most rapid and lethal form of Yersinia pestis infection. Increasing evidence suggests that Y. pestis employs multiple levels of innate immune evasion and/or suppression to produce an early "pre-inflammatory" phase of pulmonary infection, after which the disease is highly inflammatory in the lung and 100% fatal. In this study, we show that IL-1 beta/IL-18 cytokine activation occurs early after bacteria enter the lung, and this activation eventually contributes to pulmonary inflammation and pathology during the later stages of infection. However, the inflammatory effects of IL-1 beta/IL-1-receptor ligation are not observed during this first stage of pneumonic plague. We show that Y. pestis also activates the induction of IL-1 receptor antagonist (IL-1RA), and this activation likely contributes to the ability of Y. pestis to establish the initial pre-inflammatory phase of disease.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [31] IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia
    Liu, JSH
    Amaral, TD
    Brosnan, CF
    Lee, SC
    JOURNAL OF IMMUNOLOGY, 1998, 161 (04): : 1989 - 1996
  • [32] THE BALANCE BETWEEN IL-1 AND IL-1 RECEPTOR ANTAGONIST (IL-1RA) IN CROHNS-DISEASE
    DUCHINI, A
    TONELLI, F
    COMINELLI, F
    CLINICAL RESEARCH, 1992, 40 (02): : A356 - A356
  • [33] Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy
    Kanemoto, K
    Kawasaki, J
    Miyamoto, T
    Obayashi, H
    Nishimura, M
    ANNALS OF NEUROLOGY, 2000, 47 (05) : 571 - 574
  • [34] Postoperative pain, morphine consumption, and genetic polymorphism of IL-1β and IL-1 receptor antagonist
    Bessler, H.
    Shavit, Y.
    Mayburd, E.
    Smirnov, G.
    Beilin, B.
    NEUROSCIENCE LETTERS, 2006, 404 (1-2) : 154 - 158
  • [35] Differential modulation of synthesis of human IL-1 beta and IL-1 receptor antagonist by cyclosporin A
    Lufft, V
    Linneweber, S
    Lonnemann, G
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1130 - 1132
  • [36] Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis
    Kantarci, OH
    Atkinson, EJ
    Hebrink, DD
    McMurray, CT
    Weinshenker, BG
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 106 (1-2) : 220 - 227
  • [37] IL-4 RECIPROCALLY REGULATES IL-1 AND IL-1 RECEPTOR ANTAGONIST EXPRESSION IN HUMAN MONOCYTES
    FENTON, MJ
    BURAS, JA
    DONNELLY, RP
    JOURNAL OF IMMUNOLOGY, 1992, 149 (04): : 1283 - 1288
  • [38] IL-1 RECEPTOR ANTAGONIST AND POSTMENOPAUSAL OSTEOPOROSIS
    PACIFICI, R
    VANNICE, JL
    BLOEDOW, DC
    THOMPSON, RB
    KIMBLE, R
    CLINICAL RESEARCH, 1992, 40 (03): : A735 - A735
  • [39] Lack of IL-1 receptor antagonistic activity of the capsular F1 antigen of Yersinia pestis
    Krakauer, T
    Heath, D
    IMMUNOLOGY LETTERS, 1998, 60 (2-3) : 137 - 142
  • [40] AN IL-1 RECEPTOR AND AN IL-1 RECEPTOR ANTAGONIST ATTENUATE MURAMYL DIPEPTIDE- AND IL-1-INDUCED SLEEP AND FEVER
    IMERI, L
    OPP, MR
    KRUEGER, JM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04): : R907 - R913